Teleflex Incorporated (NYSE:TFX) Shares Acquired by Vontobel Holding Ltd.

Vontobel Holding Ltd. grew its stake in Teleflex Incorporated (NYSE:TFX) by 21.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,393 shares of the medical technology company’s stock after buying an additional 250 shares during the quarter. Vontobel Holding Ltd.’s holdings in Teleflex were worth $248,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of TFX. Janus Henderson Group PLC lifted its holdings in shares of Teleflex by 2.8% in the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after buying an additional 147,147 shares during the period. FMR LLC lifted its holdings in shares of Teleflex by 70.1% in the 3rd quarter. FMR LLC now owns 269,490 shares of the medical technology company’s stock valued at $66,650,000 after buying an additional 111,086 shares during the period. Assenagon Asset Management S.A. lifted its holdings in shares of Teleflex by 457.6% in the 3rd quarter. Assenagon Asset Management S.A. now owns 120,311 shares of the medical technology company’s stock valued at $29,755,000 after buying an additional 98,735 shares during the period. Point72 Asset Management L.P. lifted its holdings in shares of Teleflex by 31.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock valued at $100,768,000 after buying an additional 96,958 shares during the period. Finally, Parkman Healthcare Partners LLC acquired a new position in shares of Teleflex in the 3rd quarter valued at about $23,778,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Wall Street Analyst Weigh In

TFX has been the subject of a number of analyst reports. Mizuho reduced their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, November 1st. Royal Bank of Canada reduced their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a report on Monday, December 16th. StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Finally, Truist Financial reduced their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Price Performance

Shares of Teleflex stock opened at $175.43 on Friday. The business has a 50 day simple moving average of $177.07 and a two-hundred day simple moving average of $207.80. Teleflex Incorporated has a 12 month low of $165.62 and a 12 month high of $249.90. The stock has a market capitalization of $8.15 billion, a P/E ratio of 34.88, a PEG ratio of 1.73 and a beta of 1.16. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.